Site-specific mutagenesis of mistletoe lectin:: The role of RIP activity in apoptosis

被引:39
作者
Langer, M
Möckel, B
Eck, J
Zinke, H
Lentzen, H
机构
[1] BRAIN GmbH, D-64673 Zwingenberg, Germany
[2] MADAUS AG, D-51109 Cologne, Germany
关键词
Viscum album; ribosome-inactivating protein; viscumin; apoptosis; site-directed mutagenesis; N-riboside hydrolase (EC 3.2.2.22);
D O I
10.1006/bbrc.1999.1610
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Recombinant mistletoe lectin (rML) belongs to the class of type II ribosome-inactivating proteins (RIP) composed of a catalytically active A-chain with rRNA N-glycosidase activity and a B-chain with carbohydrate binding properties. To investigate the contribution of the enzymatic activity of the rML A-chain to the observed cytotoxic and apoptotic effects, an rMLA E166Q R169Q molecule was developed by means of site-specific mutagenesis. Following heterologous expression, the activity of mutant rMLA was measured in a cell-free assay for rRNA-N-glycosidase activity. Moreover, after generation of heterodimer, the activities of mutant rML E166Q R169Q and rML wild type were determined in a cytotoxicity and apoptosis assay. Although the reduction of activity as measured in the cell-free RIP assay was more pronounced (factor 237) than in both cellular assays (factors 20-22), the data clearly indicate a close correlation between cytotoxicity, apoptosis, and the enzymatic activity of the rML A-chain. Thus, RIP activity is an essential feature of rML and therefore a prerequisite for its biological function as an anticancer agent. (C) 1999 Academic Press.
引用
收藏
页码:944 / 948
页数:5
相关论文
共 27 条
[1]   REMOVAL OF A PROTEOLYTIC ACTIVITY ASSOCIATED WITH AGGREGATES FORMED FROM EXPRESSION OF CREATINE-KINASE IN ESCHERICHIA-COLI LEADS TO IMPROVED RECOVERY OF ACTIVE ENZYME [J].
BABBITT, PC ;
WEST, BL ;
BUECHTER, DD ;
KUNTZ, ID ;
KENYON, GL .
BIO-TECHNOLOGY, 1990, 8 (10) :945-949
[2]   RIBOSOME-INACTIVATING PROTEINS FROM PLANTS [J].
BARBIERI, L ;
BATTELLI, MG ;
STIRPE, F .
BIOCHIMICA ET BIOPHYSICA ACTA, 1993, 1154 (3-4) :237-282
[3]  
BEUTH J, 1993, ARZNEIMITTEL-FORSCH, V43-1, P166
[4]  
Beuth J., 1997, ANTI CANC DRUGS, V8, P53
[5]  
BOCCI V, 1993, J BIOL REG HOMEOS AG, V7, P1
[6]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[7]   SITE-DIRECTED MUTAGENESIS OF VIRTUALLY ANY PLASMID BY ELIMINATING A UNIQUE SITE [J].
DENG, WP ;
NICKOLOFF, JA .
ANALYTICAL BIOCHEMISTRY, 1992, 200 (01) :81-88
[8]  
Doser C., 1989, DRUG RES, V39, P647
[9]   Characterization of recombinant and plant-derived mistletoe lectin and their B-chains [J].
Eck, J ;
Langer, M ;
Möckel, B ;
Witthohn, K ;
Zinke, H ;
Lentzen, H .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1999, 265 (02) :788-797
[10]   Cloning of the mistletoe lectin gene and characterization of the recombinant A-chain [J].
Eck, J ;
Langer, M ;
Möckel, B ;
Baur, A ;
Rothe, M ;
Zinke, H ;
Lentzen, H .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1999, 264 (03) :775-784